Skip to main content
ORTIN GLOBAL LIMITED logo

ORTIN GLOBAL LIMITED — Investor Relations & Filings

Ticker · ORTINGLOBE ISIN · INE749B01020 BSE.NS Manufacturing
Open in API
Filings indexed 207 across all filing types
Latest filing 2022-08-17 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS ORTINGLOBE

About ORTIN GLOBAL LIMITED

https://www.ortinlabsindia.com/

Ortin Global Limited is a pharmaceutical enterprise engaged in the development, manufacture, and marketing of active pharmaceutical ingredients (APIs), intermediates, and finished dosage formulations. The company maintains a diverse product portfolio covering various therapeutic segments, such as anti-diabetics, anti-hypertensives, anti-retrovirals, analgesics, and anti-pyretics. Its operations include the synthesis of complex chemical molecules and the production of oral solids and liquids, including tablets, capsules, and syrups. With a focus on integrated manufacturing processes, the company serves both domestic and international healthcare markets. Ortin Global Limited prioritizes research and development to expand its product offerings and optimize production techniques, ensuring compliance with established quality standards across its manufacturing facilities.

Recent filings

Filing Released Lang Actions
Newspaper Advertisements
Interim / Quarterly Report Classification · 95% confidence The document contains unaudited financial results for the quarter ended 30.06.2022, including detailed financial data such as total income, net profit/loss before and after tax, comprehensive income, equity share capital, reserves, and earnings per share. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and includes extracts of quarterly financial results reviewed by the Audit Committee and approved by the Board of Directors. The presence of substantive financial data and analysis for a quarter indicates this is a quarterly financial report rather than a mere announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2022-08-17 English
Outcome of Board Meeting
Interim / Quarterly Report Classification · 100% confidence The document is dated 13.08.2022 and is addressed to the National Stock Exchange of India Limited. It reports the outcome of a Board meeting held on the same date where the company approved the unaudited financial results for the quarter ended 30.06.2022 and the Limited Review Report as per SEBI regulations. The document includes detailed unaudited financial results for the quarter, notes explaining the preparation and review of these results, and an Independent Auditor's Review Report on the quarterly and year-to-date unaudited financial results. The presence of actual financial data, the quarterly period reference, and the auditor's review report indicate this is a comprehensive interim financial report for a period shorter than a full fiscal year. Therefore, this document fits the definition of an Interim / Quarterly Report (IR).
2022-08-13 English
Board Meeting — Financial results
Regulatory Filings Classification · 95% confidence The document text is extremely short (122 characters) and contains no substantive content, only placeholders for omitted pictures. There is no financial data, report title, regulatory references, or any descriptive text. Given the lack of content, this cannot be classified as a report or announcement of a report. It fits best as a Regulatory Filing (RNS) as a fallback category for miscellaneous filings with no clear classification.
2022-07-27 English
General updates
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018, for the quarter ended June 30, 2022. It is addressed to stock exchanges and certifies that details of securities dematerialized/rematerialized have been furnished as required. The document is short (3373 characters) and is a certificate of compliance rather than a financial report or detailed filing. It does not contain financial statements or management discussion but is a regulatory compliance certificate. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance document and not a full report or announcement of a report.
2022-07-09 English
Closure of trading window
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) informing about the closure of the trading window under SEBI (Prohibition of Insider Trading) Regulations, 2015. It specifies the trading window closure period related to the financial results announcement for the quarter ended 30.06.2022. The content is a regulatory compliance announcement related to insider trading restrictions, not a financial report, earnings release, or any detailed financial data. It is a regulatory filing informing the exchanges about the trading window closure period. The document length is short (902 characters), and it is not a report or presentation but a notification to exchanges. Therefore, the appropriate classification is Regulatory Filings (RNS).
2022-06-29 English
Related Party Transaction
Regulatory Filings
2022-06-13 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.